Skip to content

Resolute Integrity™ RSINT30018WRecalls & reported problems

Medtronic, Inc. · Stent RSINT30018W MicroTrac 3.00X18OTW · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613994793409), received between Feb 19, 2020 and Feb 19, 2020 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Reaction1
  • Unspecified Infection1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 19, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT IS REPORTED THAT A PATIENT HAD TWO RESOLUTE INTEGRITY DRUG-ELUTING STENTS IMPLANTED. IT IS REPORTED THAT THE PATIENT WAS HAVING BREAKOUTS AND A RASH THAT WAS GETTING WORSE, SINCE HAVING THE DEVICES IMPLANTED. IT IS STATED THAT THE PATIENT HAD TESTED POSITIVE FOR ALLERGIES TO NICKEL AND CHROMIUM.

    Patient problems: Reaction; Unspecified Infection

    MAUDE report 9726625 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page